Anti-GQ1b antibody syndrome presenting with visual deterioration as the initial symptom: A case report

Medicine (Baltimore). 2020 Jan;99(4):e18805. doi: 10.1097/MD.0000000000018805.

Abstract

Rationale: Anti-GQ1b antibody syndrome refers to a distinct variant of Guillain- Barré syndrome. Involvement of the optic nerve in anti-GQ1b antibody syndrome is extremely rare.

Patient concerns: Here, we report a case of anti-GQ1b antibody syndrome presenting with visual deterioration as the initial symptom. A 73-year-old man presented with a 5-day history of bilateral blurred vision and ptosis. He had a previous history of diarrhea starting 10 days before admission. Physical examination showed visual deterioration, ophthalmoplegia, and peripheral facial paralysis. Testing of both serum and cerebrospinal fluid was positive for anti-GQ1b immunoglobulin G antibodies and negative for anti-aquaporin 4antibodies.

Diagnosis: Anti-GQ1b antibody syndrome.

Interventions: The patient was treated with intravenous methylprednisolone and human immunoglobulin.

Outcomes: After a 20-day follow-up, the patient's condition took a favorable turn.

Lessons: This case reminds us that anti-GQ1b antibody syndrome should be suspected in patients with visual deterioration and preceding infection.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Autoantibodies / blood
  • Guillain-Barre Syndrome / blood
  • Guillain-Barre Syndrome / classification
  • Guillain-Barre Syndrome / diagnosis*
  • Guillain-Barre Syndrome / drug therapy
  • Humans
  • Immunoglobulin G / blood*
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Male
  • Ophthalmoplegia / diagnosis
  • Ophthalmoplegia / etiology
  • Syndrome
  • Vision Disorders / etiology

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Immunoglobulins, Intravenous
  • Immunologic Factors